Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Prospective, Controlled, Randomized Clinical Trial to Evaluate the Effectiveness of Four Analgesic Methods During Trans Rectal Prostate Biopsy.
1 other identifier
observational
70
1 country
1
Brief Summary
Define the best analgesic method between peri prostatic blockage, analgesic suppository, oral analgesic and topic anesthetic gel, during trans rectal prostate biopsy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2017
CompletedFirst Submitted
Initial submission to the registry
February 10, 2018
CompletedFirst Posted
Study publicly available on registry
February 22, 2018
CompletedMarch 27, 2018
March 1, 2018
3 months
February 10, 2018
March 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ultrasound Transducer
Evaluation of the discomfort or pain in the introduction of the trans rectal ultrasound transducer determined at the end of the procedure with Visual Analog Scale for Pain, which is a psychometric measuring instrument designed to assess the pain intensity experienced by each patient individually. Was employ for first time in 1921 and referred as a "graphical rating method", which has the characteristic of being able to achieve a rapid classification (statistically measurable and reproducible) of the severity of pain experience. The analogous visual scale used for this study measures from 0-10 the intensity of the pain with a series of "faces" that show the intensity in the pain experimentation with categories like "No pain" approximately 0-1, mild, annoying in number 2, nagging in number 4, distressing in number 6, intense in number 8 and worst possible in number 10.
Interview 15 to 30 minutes at the end of the procedure
Secondary Outcomes (1)
Biopsy
Interview 15 to 30 minutes at the end of the procedure
Other Outcomes (1)
General procedure
Interview 15 to 30 minutes at the end of the procedure
Study Arms (5)
Group 1
Group 1 an analgesic suppository was applied
Group 2
Group 2 was administered analgesic orally
Group 3
Group 3 was given trans rectal gel
Group 4
Group was performed peri prostatic infiltration.
Group 5
Group was performed by placebo oral
Eligibility Criteria
The patients from the consultation were taken from the first time they were derived from the peripheral clinics or from the ones derived from our same medicine, with suspicion of prostate cancer and that the criteria for carrying out the trans rectal prostate biopsy were met.
You may qualify if:
- Male patients older than 18 years with indication for trans rectal prostate biopsy
You may not qualify if:
- Bad intestinal preparation.
- Painful anorectal pathologies.
- Clotting disorders without previous assessment by hematology.
- Acute prostatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edgar Beltran-Suarez
Mexico City, Aztcapotzalco, 07300, Mexico
Related Publications (6)
Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, Drake CG, de Bono JS. Prostate cancer. Lancet. 2016 Jan 2;387(10013):70-82. doi: 10.1016/S0140-6736(14)61947-4. Epub 2015 Jun 11.
PMID: 26074382BACKGROUNDLowrance WT, Roth BJ, Kirkby E, Murad MH, Cookson MS. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2015. J Urol. 2016 May;195(5):1444-1452. doi: 10.1016/j.juro.2015.10.086. Epub 2015 Oct 20.
PMID: 26498056BACKGROUNDLoeb S, Vellekoop A, Ahmed HU, Catto J, Emberton M, Nam R, Rosario DJ, Scattoni V, Lotan Y. Systematic review of complications of prostate biopsy. Eur Urol. 2013 Dec;64(6):876-92. doi: 10.1016/j.eururo.2013.05.049. Epub 2013 Jun 4.
PMID: 23787356BACKGROUNDMottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. Actas Urol Esp. 2011 Nov-Dec;35(10):565-79. doi: 10.1016/j.acuro.2011.03.011. Epub 2011 Jul 14. Spanish.
PMID: 21757258BACKGROUNDHerranz Amo F, Diez Cordero JM, Cabello Benavente R. [Evolution of the transrectal ultrasound guided prostatic biopsy technique]. Arch Esp Urol. 2006 May;59(4):385-96. Spanish.
PMID: 16800136BACKGROUNDSahin A, Ceylan C, Gazel E, Odabas O. Three different anesthesia techniques for a comfortable prostate biopsy. Urol Ann. 2015 Jul-Sep;7(3):339-44. doi: 10.4103/0974-7796.152014.
PMID: 26229322BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
EDGAR BELTRAN-SUAREZ, MD
HOSPITAL OF SPECIALTIES OF THE NATIONAL MEDICAL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Edgar Beltran-Suarez
Study Record Dates
First Submitted
February 10, 2018
First Posted
February 22, 2018
Study Start
May 1, 2017
Primary Completion
July 31, 2017
Study Completion
July 31, 2017
Last Updated
March 27, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share